UNC receives $40M to use AI for personalized cancer vaccines

UNC-Chapel Hill has received $40 million from the OpenAI foundation nonprofit for a four-year project called "Generative Immunotherapy" to use AI to create personalized cancer vaccines. The first trial will target triple-negative breast cancer patients after surgery, with data from 75 people collected to identify optimal tumor targets.

• Australian universities expand ChatGPT access to build AI-native graduates2026-11-06
• Franklin Templeton taps OpenAI for investment research2026-11-06
• Cult.fit uses Codex to boost operational efficiency2026-11-06
• Merge builds product and business tools with OpenAI technology2026-11-06
• Perplexity launches work-focused AI agents called Teammates2026-11-05